Monoclonal Antibodies

Polymorphism rs4919510:C>G in Mature Sequence of Human MicroRNA-608 Contributes to the Risk of HER2-Positive Breast Cancer but Not Other Subtypes.
PLoS One. 2012;7(5):e35252
Authors: Huang AJ, Yu KD, Li J, Fan L, Shao ZM

Continue reading about Polymorphism rs4919510:C>G in Mature Sequence of Human MicroRNA-608 Contributes to the Risk of HER2-Positive Breast Cancer but Not Other Subtypes.

HER2-Positive Male Breast Cancer with Thyroid Cancer: an Institutional Report and Review of Literature.
Ann Clin Lab Sci. 2012;42(2):135-9
Authors: Bardhan P, Bui MM, Minton S, Loftus L, Carter WB, Laronga C, Ismail-Khan R

Continue reading about HER2-Positive Male Breast Cancer with Thyroid Cancer: an Institutional Report and Review of Literature.

PET of HER2-Positive Pulmonary Metastases with 18F-ZHER2:342 Affibody in a Murine Model of Breast Cancer: Comparison with 18F-FDG.
J Nucl Med. 2012 May 11;
Authors: Kramer-Marek G, Bernardo M, Kiesewetter DO, Bagci U, Kuban …

Continue reading about PET of HER2-Positive Pulmonary Metastases with 18F-ZHER2:342 Affibody in a Murine Model of Breast Cancer: Comparison with 18F-FDG.

HER2 Signaling and Resistance to the Anti-EGFR Monoclonal Antibody Cetuximab: A Further Step toward Personalized Medicine for Patients with Colorectal Cancer.
Cancer Discov. 2011 Nov;1(6):472-4
Authors: Ciardiello F, Normann…

Continue reading about HER2 Signaling and Resistance to the Anti-EGFR Monoclonal Antibody Cetuximab: A Further Step toward Personalized Medicine for Patients with Colorectal Cancer.

Development of a human monoclonal antibody for potential therapy of CD27-expressing lymphoma and leukemia.
Clin Cancer Res. 2012 May 15;
Authors: Vitale L, He LZ, Thomas LJ, Widger J, Weidlick J, Crocker A, O’Neill T, Storey…

Continue reading about Development of a human monoclonal antibody for potential therapy of CD27-expressing lymphoma and leukemia.

Development and characterization of murine monoclonal antibodies to first and second Ljungan virus genotypes.
J Virol Methods. 2012 May 10;
Authors: Kallies R, Arbrandt G, Niklasson B, Niedrig M
Abstract
Ljun…

Continue reading about Development and characterization of murine monoclonal antibodies to first and second Ljungan virus genotypes.

Early Stage Triple Negative and HER2 Overexpression Breast Cancers Have Similar Survivals in Chinese Patients.
Breast J. 2012 May;18(3):286-8
Authors: Zhang Q, Tang SC, Liu H
PMID: 22583198 [PubMed - in process]

Continue reading about Early Stage Triple Negative and HER2 Overexpression Breast Cancers Have Similar Survivals in Chinese Patients.

SRC Inhibition Overcomes Trastuzumab Resistance in HER2-Overexpressing Breast Cancers.
Cancer Discov. 2011 Jun;1(1):11
Authors:
PMID: 22586311 [PubMed - in process]

Continue reading about SRC Inhibition Overcomes Trastuzumab Resistance in HER2-Overexpressing Breast Cancers.

Re: Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria.
J Natl Cancer Inst. 2012 May 10;
Authors: Wolff AC, Hammond ME, Hayes DF
PMID: 22581974 [PubMed – as s…

Continue reading about Re: Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria.

Development and characterization of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009).
J Virol Methods. 2012 Jul;183(1):25-33
Authors: Cabral TM, Berhane Y, Schmidt L, Tracz DM, Hole K, Leith M, Corbe…

Continue reading about Development and characterization of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009).